Scarica l'app Stockscreener
1.02
0.99%
0.01
Dopo l'orario di chiusura:
.99
-0.03
-2.94%
Precedente Chiudi:
$1.01
Aprire:
$0.9825
Volume 24 ore:
164.62K
Relative Volume:
0.16
Capitalizzazione di mercato:
$5.12M
Reddito:
$6,200
Utile/perdita netta:
$-24.48M
Rapporto P/E:
-0.2101
EPS:
-4.8539
Flusso di cassa netto:
$-4.92M
1 W Prestazione:
+12.09%
1M Prestazione:
-29.66%
6M Prestazione:
-93.93%
1 anno Prestazione:
-95.79%
Intervallo 1D:
$0.8853
$1.02
Intervallo di 1 settimana:
$0.82
$1.09
Portata 52W:
$0.5483
$35.01
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Nome
Aspire Biopharma Holdings Inc
Settore
Industria
Telefono
561-704-8527
Indirizzo
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
1.02 | 5.12M | 6,200 | -24.48M | -4.92M | -4.8539 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Greenville Online
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Fundamental Analysis & Valuation - ChartMill
ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - patriotledger.com
Aspire Biopharma Provides Q3 2025 Business Update - columbiadailyherald.com
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - Burlington Free Press
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Record-Courier
Aspire Biopharma: Disruptive Sublingual Drug Delivery Technology, Pipeline, and Patent Portfolio Overview 798289 - Minichart
Aspire Biopharma 10-K: Revenue $6.2K, Net Loss $24.48M - TradingView
Reverse recap and sublingual pipeline reshape Aspire Biopharma (NASDAQ: ASBP) - Stock Titan
Aspire Biopharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - patriotledger.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ASBP Soars: Biotech Turbulence Fuels an Unexpected 17% Jump - bitget.com
Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - ACCESS Newswire
Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Black Hills Pioneer
ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Aspire Biopharma's Subsidiary Announces Retail Expansion Deal - National Today
Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget
Aspire subsidiary names John Choe as western sales director By Investing.com - Investing.com South Africa
Aspire subsidiary names John Choe as western sales director - Investing.com
He drove 70% sales growth at Yerbaé — now Buzz Bomb hires him - Stock Titan
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - The Gardner News
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Erie Times-News
Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - Democrat and Chronicle
Aspire Biopharma Holdings Inc Azioni (ASBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):